RT Journal Article
SR Electronic
T1 A New Extension of State-Space SIR Model to Account for Underreporting- An Application to the COVID-19 transmission in California and Florida
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.20.20248580
DO 10.1101/2020.12.20.20248580
A1 Vishal Deo
A1 Gurprit Grover
YR 2020
UL http://medrxiv.org/content/early/2020/12/22/2020.12.20.20248580.abstract
AB In the absence of sufficient testing capacity for COVID-19, a substantial number of infecteds are expected to remain undetected. Since the undetected cases are not quarantined, they are expected to transmit the infection at a much higher rate than their quarantined counterparts. That is, under the lack of extensive random testing, the actual prevalence and incidence of the SARS-CoV-2 infection may be entirely different from that being reported. Thus, it is imperative that the information on the percentage of undetected (or unreported) cases be considered while estimating the parameters and forecasting the transmission dynamics of the epidemic.In this paper, we have developed a new version of the basic susceptible-infected-removed (SIR) compartmental model, called the susceptible-infected (quarantined/ free) -recovered-deceased [SI(Q/F)RD] model, to incorporate the impact of undetected cases on the transmission dynamics of the epidemic. Further, we have presented a Dirichlet-Beta state-space formulation of the SI(Q/F)RD model for the estimation of its parameters using posterior realizations from Gibbs sampling procedure. As a demonstration, the proposed methodology is implemented to forecast the COVID-19 transmission in California and Florida.HighlightsData calibrated for underreporting using excess deaths and case fatality rate.A new extension of SIR compartmental model, called SI(Q/F)RD, is introduced.A Dirichlet-Beta state-space formulation of the SI(Q/F)RD model is developed.Gibbs sampling used to estimate the Bayesian hierarchical state-space model.Proposed methodology is applied on the COVID-19 data of California and Florida.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is procured from the github repository of Johns Hopkins University https://github.com/CSSEGISandData/COVID-19